![Martin Juhl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Juhl is currently Chief Scientific Officer & Head-Device Development at Cessatech A, a position held since 2022.
Education includes a graduate degree from the University of Copenhagen.
| Società | Posizione | Inizio |
|---|---|---|
| CESSATECH A/S | Direttore Tecnico/Scientifico/R&S | 01/03/2022 |
Attive
Inattive
Società nel listino
Aziende private
| Aziende private | 3 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cessatech A/S
 Cessatech A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for children for the treatment of pediatric acute pain | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
